Mạng xã hội teleconcepts.net Mạng xã hội teleconcepts.net
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Offers
  • Jobs
  • Postari
  • Articles
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • Nikita Pawar a adăugat un fișier Alte
    2025-11-06 11:35:15 -
    Antibody Drug Conjugate Market Outlook Strengthened by R&D Collaborations
    The global antibody drug conjugate (ADC) market is experiencing rapid growth driven by the rising prevalence of cancer, advancements in targeted therapy, and continuous innovation in antibody engineering and cytotoxic payload technologies. Valued at USD 12.70 billion in 2024, the market is projected to expand to USD 14.20 billion in 2025 and further reach USD 35.40 billion by 2032, registering...
    0 Commentarii 0 Distribuiri 1554 Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Sunita Lawankar a adăugat un fișier Alte
    2025-11-07 10:35:27 -
    Antibody Drug Conjugate Market Size, Trends, and Dynamics Unveiled
    The global Antibody Drug Conjugate market is a dynamic and promising industry that has shown significant growth in recent years. According to Extrapolates recent market study, the Antibody Drug Conjugate market was valued at USD 14.20 billion in 2024 and is expected to reach USD 35.40 billion by 2031, exhibiting a robust CAGR of 13.94% over the forecast period of 2024-2031. This report provides...
    0 Commentarii 0 Distribuiri 1617 Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Divakar Kolhe a adăugat un fișier Health
    2026-02-03 07:16:30 -
    Next-Generation ADCs and Their Impact on the Antibody Drug Conjugate Market
    The landscape of oncology is shifting from broad-spectrum treatments toward "biological missiles" that target cancer with surgical precision. At the heart of this transformation is the Antibody Drug Conjugate Market. By combining the targeting capabilities of monoclonal antibodies with the cell-killing power of cytotoxic drugs, ADCs are redefining survival rates for patients worldwide. The...
    0 Commentarii 0 Distribuiri 119 Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2026 Mạng xã hội teleconcepts.net Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Tiếng Việt
About Termeni Confidențialitate Contacteaza-ne Director